Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 10:49 PM
Ignite Modification Date:
2025-12-25 @ 8:18 PM
NCT ID:
NCT01421069
Pre Assignment Details:
Total 127 participants were enrolled and treated in parent study, B1801014 (NCT00962741) and included in analysis of this extension study. Total 109 participants from the Parent study were enrolled in this extension study, B1801023. Out of which 10 participants directly entered into observational phase and did not receive treatment in this extension study. The extension study has 3 periods: active treatment period, withdrawal/re-treatment period and observational period.
Recruitment Details:
This was an extension study in pediatric participants diagnosed with one of three subtypes of juvenile idiopathic arthritis (JIA): extended oligoarticular JIA, enthesitis related arthritis (ERA), or psoriatic arthritis (PsA) and had received at least one dose of Etanercept and completed approximately 96 weeks of participation in study B1801014 (NCT00962741).
Study:
NCT01421069
Study Brief:
Results Section:
NCT01421069